-
1
-
-
0034656345
-
ABC of arterial and venous disease. Vascular complications of diabetes
-
R. Donnelly, A.M. Emslie-Smith, I.D. Gardner, and A.D. Morris Abc of arterial and venous disease: vascular complications of diabetes BMJ 320 2000 1062 1066 (Pubitemid 30198980)
-
(2000)
British Medical Journal
, vol.320
, Issue.7241
, pp. 1062-1066
-
-
Donnelly, R.1
Emslie-Smith, A.M.2
Garnder, I.D.3
Morris, A.D.4
-
2
-
-
79951810203
-
-
accessed24.05.2010
-
http://www.Diabetes.Org/diabetes-basics/diabetes-statistics/ [accessed 24.05.2010].
-
-
-
-
3
-
-
75149129619
-
Cardiovascular disease in type 2 diabetes from population to man to mechanisms: The Kelly west award lecture 2008
-
M. Laakso Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly west award lecture 2008 Diabetes Care 33 2010 442 449
-
(2010)
Diabetes Care
, vol.33
, pp. 442-449
-
-
Laakso, M.1
-
4
-
-
0041819882
-
Diabetes mellitus and heart failure
-
D. Jagasia, and P.H. McNulty Diabetes mellitus and heart failure Congest Heart Fail 9 2003 133 139 [quiz 140-131]
-
(2003)
Congest Heart Fail
, vol.9
, pp. 133-139
-
-
Jagasia, D.1
McNulty, P.H.2
-
5
-
-
36649035304
-
Management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy - Update regarding the thiazolidinediones
-
DOI 10.1007/s00125-007-0873-z
-
D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, and R. Sherwin Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones Diabetologia 51 2008 8 11 (Pubitemid 50004100)
-
(2008)
Diabetologia
, vol.51
, Issue.1
, pp. 8-11
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Ferrannini, E.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
6
-
-
77950507168
-
Heart failure events with rosiglitazone in type 2 diabetes: Data from the record clinical trial
-
M. Komajda, J.J. McMurray, H. Beck-Nielsen, R. Gomis, M. Hanefeld, and S.J. Pocock Heart failure events with rosiglitazone in type 2 diabetes: data from the record clinical trial Eur Heart J 31 2010 824 831
-
(2010)
Eur Heart J
, vol.31
, pp. 824-831
-
-
Komajda, M.1
McMurray, J.J.2
Beck-Nielsen, H.3
Gomis, R.4
Hanefeld, M.5
Pocock, S.J.6
-
7
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2007 2457 2471 (Pubitemid 46919772)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.24
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
8
-
-
34548580881
-
Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis
-
DOI 10.1001/jama.298.10.1189
-
S. Singh, Y.K. Loke, and C.D. Furberg Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis JAMA 298 2007 1189 1195 (Pubitemid 47403105)
-
(2007)
Journal of the American Medical Association
, vol.298
, Issue.10
, pp. 1189-1195
-
-
Singh, S.1
Loke, Y.K.2
Furberg, C.D.3
-
9
-
-
0033864582
-
Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
-
A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in ldl receptor-deficient mice J Clin Invest 106 2000 523 531 (Pubitemid 30666385)
-
(2000)
Journal of Clinical Investigation
, vol.106
, Issue.4
, pp. 523-531
-
-
Li, A.C.1
Brown, K.K.2
Silvestre, M.J.3
Willson, T.M.4
Palinski, W.5
Glass, C.K.6
-
10
-
-
0036314839
-
Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size
-
DOI 10.1096/fj.01-0793com
-
N.S. Wayman, Y. Hattori, M.C. McDonald, H. Mota-Filipe, S. Cuzzocrea, and B. Pisano Ligands of the peroxisome proliferator-activated receptors (ppar-gamma and ppar-alpha) reduce myocardial infarct size FASEB J 16 2002 1027 1040 (Pubitemid 34753509)
-
(2002)
FASEB Journal
, vol.16
, Issue.9
, pp. 1027-1040
-
-
Wayman, N.S.1
Hattori, Y.2
Mcdonald, M.C.3
Mota-Filipe, H.4
Cuzzocrea, S.5
Pisano, B.6
Chatterjee, P.K.7
Thiemermann, C.8
-
11
-
-
1542268988
-
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion
-
DOI 10.1016/j.cardiores.2003.12.027, PII S0008636304000033
-
H.R. Liu, L. Tao, E. Gao, B.L. Lopez, T.A. Christopher, and R.N. Willette Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion Cardiovasc Res 62 2004 135 144 (Pubitemid 38326819)
-
(2004)
Cardiovascular Research
, vol.62
, Issue.1
, pp. 135-144
-
-
Liu, H.-R.1
Tao, L.2
Gao, E.3
Lopez, B.L.4
Christopher, T.A.5
Willette, R.N.6
Ohlstein, E.H.7
Yue, T.-L.8
Ma, X.-L.9
-
12
-
-
77951128682
-
Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome
-
A.J. Rennings, P. Meijer, D.J. van Uden, C.J. Tack, P. Smits, and O.C. Boerman Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome Eur Heart J 31 2010 983
-
(2010)
Eur Heart J
, vol.31
, pp. 983
-
-
Rennings, A.J.1
Meijer, P.2
Van Uden, D.J.3
Tack, C.J.4
Smits, P.5
Boerman, O.C.6
-
13
-
-
66049138419
-
Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mtor activation
-
W.T. Festuccia, M. Laplante, S. Brule, V.P. Houde, A. Achouba, and D. Lachance Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mtor activation J Mol Cell Cardiol 47 2009 85 95
-
(2009)
J Mol Cell Cardiol
, vol.47
, pp. 85-95
-
-
Festuccia, W.T.1
Laplante, M.2
Brule, S.3
Houde, V.P.4
Achouba, A.5
Lachance, D.6
-
14
-
-
76349098660
-
Adiponectin: An indispensable molecule in rosiglitazone cardioprotection following myocardial infarction
-
L. Tao, Y. Wang, E. Gao, H. Zhang, Y. Yuan, and W.B. Lau Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction Circ Res 106 2009 409 417
-
(2009)
Circ Res
, vol.106
, pp. 409-417
-
-
Tao, L.1
Wang, Y.2
Gao, E.3
Zhang, H.4
Yuan, Y.5
Lau, W.B.6
-
16
-
-
4744369936
-
The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence
-
DOI 10.1111/j.1365-277X.2004.00552.x
-
C.H. Ruxton, S.C. Reed, M.J. Simpson, and K.J. Millington The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence J Hum Nutr Diet 17 2004 449 459 (Pubitemid 39307100)
-
(2004)
Journal of Human Nutrition and Dietetics
, vol.17
, Issue.5
, pp. 449-459
-
-
Ruxton, C.H.S.1
Reed, S.C.2
Simpson, M.J.A.3
Millington, K.J.4
-
18
-
-
0037951860
-
Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice
-
DOI 10.1359/jbmr.2003.18.7.1206
-
D. Sun, A. Krishnan, K. Zaman, R. Lawrence, A. Bhattacharya, and G. Fernandes Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice J Bone Miner Res 18 2003 1206 1216 (Pubitemid 37294913)
-
(2003)
Journal of Bone and Mineral Research
, vol.18
, Issue.7
, pp. 1206-1216
-
-
Sun, D.1
Krishnan, A.2
Zaman, K.3
Lawrence, R.4
Bhattacharya, A.5
Fernandes, G.6
-
19
-
-
77954509972
-
Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice
-
G.V. Halade, M.M. Rahman, A. Bhattacharya, J.L. Barnes, B. Chandrasekar, and G. Fernandes Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice J Immunol 184 2010 5280 5286
-
(2010)
J Immunol
, vol.184
, pp. 5280-5286
-
-
Halade, G.V.1
Rahman, M.M.2
Bhattacharya, A.3
Barnes, J.L.4
Chandrasekar, B.5
Fernandes, G.6
-
20
-
-
33745607390
-
Diet and lifestyle recommendations revision 2006: A scientific statement from the American heart association nutrition committee
-
DOI 10.1161/CIRCULATIONAHA.106.176158, PII 0000301720060704000016
-
A.H. Lichtenstein, L.J. Appel, M. Brands, M. Carnethon, S. Daniels, and H.A. Franch Diet and lifestyle recommendations revision 2006: a scientific statement from the american heart association nutrition committee Circulation 114 2006 82 96 (Pubitemid 44305278)
-
(2006)
Circulation
, vol.114
, Issue.1
, pp. 82-96
-
-
Lichtenstein, A.H.1
Appel, L.J.2
Brands, M.3
Carnethon, M.4
Daniels, S.5
Franch, H.A.6
Franklin, B.7
Kris-Etherton, P.8
Harris, W.S.9
Howard, B.10
Karanja, N.11
Lefevre, M.12
Rudel, L.13
Sacks, F.14
Van Horn, L.15
Winston, M.16
Wylie-Rosett, J.17
-
21
-
-
58449105597
-
Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction
-
M.K. Duda, K.M. O'Shea, A. Tintinu, W. Xu, R.J. Khairallah, and B.R. Barrows Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction Cardiovasc Res 81 2009 319 327
-
(2009)
Cardiovasc Res
, vol.81
, pp. 319-327
-
-
Duda, M.K.1
O'Shea, K.M.2
Tintinu, A.3
Xu, W.4
Khairallah, R.J.5
Barrows, B.R.6
-
22
-
-
34250847265
-
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
-
DOI 10.1210/en.2006-1587
-
O.P. Lazarenko, S.O. Rzonca, W.R. Hogue, F.L. Swain, L.J. Suva, and B. Lecka-Czernik Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone Endocrinology 148 2007 2669 2680 (Pubitemid 46984815)
-
(2007)
Endocrinology
, vol.148
, Issue.6
, pp. 2669-2680
-
-
Lazarenko, O.P.1
Rzonca, S.O.2
Hogue, W.R.3
Swain, F.L.4
Suva, L.J.5
Lecka-Czernik, B.6
-
23
-
-
40449086665
-
Dose translation from animal to human studies revisited
-
DOI 10.1096/fj.07-9574LSF
-
S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J 22 2008 659 661 (Pubitemid 351348146)
-
(2008)
FASEB Journal
, vol.22
, Issue.3
, pp. 659-661
-
-
Reagan-Shaw, S.1
Nihal, M.2
Ahmad, N.3
-
24
-
-
67349156361
-
Pan-ppar agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet
-
C. Fernandes-Santos, R.E. Carneiro, L. de Souza Mendonca, M.B. Aguila, and C.A. Mandarim-de-Lacerda Pan-ppar agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet Nutrition 25 2009 818 827
-
(2009)
Nutrition
, vol.25
, pp. 818-827
-
-
Fernandes-Santos, C.1
Carneiro, R.E.2
De Souza Mendonca, L.3
Aguila, M.B.4
Mandarim-De-Lacerda, C.A.5
-
25
-
-
78249259079
-
High fat diet-induced animal model of age-associated obesity and osteoporosis
-
10.1016/j.jnutbio.2009.10.002
-
G.V. Halade, M.M. Rahman, P.J. Williams, and G. Fernandes High fat diet-induced animal model of age-associated obesity and osteoporosis J Nutr Biochem 2010 10.1016/j.jnutbio.2009.10.002
-
(2010)
J Nutr Biochem
-
-
Halade, G.V.1
Rahman, M.M.2
Williams, P.J.3
Fernandes, G.4
-
26
-
-
78649828932
-
Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice
-
G.V. Halade, A. El Jamali, P.J. Williams, R.J. Fajardo, and G. Fernandes Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice Exp Gerontol 46 2011 43 52
-
(2011)
Exp Gerontol
, vol.46
, pp. 43-52
-
-
Halade, G.V.1
El Jamali, A.2
Williams, P.J.3
Fajardo, R.J.4
Fernandes, G.5
-
27
-
-
16344385466
-
Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function
-
DOI 10.1016/j.cardiores.2004.11.029
-
M.L. Lindsey, D.K. Goshorn, C.E. Squires, G.P. Escobar, J.W. Hendrick, and J.T. Mingoia Age-dependent changes in myocardial matrix metalloproteinase/ tissue inhibitor of metalloproteinase profiles and fibroblast function Cardiovasc Res 66 2005 410 419 (Pubitemid 40471056)
-
(2005)
Cardiovascular Research
, vol.66
, Issue.2
, pp. 410-419
-
-
Lindsey, M.L.1
Goshorn, D.K.2
Squires, C.E.3
Escobar, G.P.4
Hendrick, J.W.5
Mingoia, J.T.6
Sweterlitsch, S.E.7
Spinale, F.G.8
-
28
-
-
0033932709
-
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
-
A. Ducharme, S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, and L.E. Rohde Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction J Clin Invest 106 2000 55 62 (Pubitemid 30437240)
-
(2000)
Journal of Clinical Investigation
, vol.106
, Issue.1
, pp. 55-62
-
-
Ducharme, A.1
Frantz, S.2
Aikawa, M.3
Rabkin, E.4
Lindsey, M.5
Rohde, L.E.6
Schoen, F.J.7
Kelly, R.A.8
Werb, Z.9
Libby, P.10
Lee, R.T.11
-
29
-
-
0024229140
-
Diet-induced type II diabetes in C57BL/6J mice
-
R.S. Surwit, C.M. Kuhn, C. Cochrane, J.A. McCubbin, and M.N. Feinglos Diet-induced type ii diabetes in c57bl/6j mice Diabetes 37 1988 1163 1167 (Pubitemid 19035045)
-
(1988)
Diabetes
, vol.37
, Issue.9
, pp. 1163-1167
-
-
Surwit, R.S.1
Kuhn, C.M.2
Cochrane, C.3
McCubbin, J.A.4
Feinglos, M.N.5
-
30
-
-
55849114349
-
Adipocytokines and the metabolic complications of obesity
-
N. Rasouli, and P.A. Kern Adipocytokines and the metabolic complications of obesity J Clin Endocrinol Metab 93 2008 S64 73
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 64-73
-
-
Rasouli, N.1
Kern, P.A.2
-
31
-
-
0031014830
-
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
-
G. Boden Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 1997 3 10 (Pubitemid 27009941)
-
(1997)
Diabetes
, vol.46
, Issue.1
, pp. 3-10
-
-
Boden, G.1
-
32
-
-
0344197476
-
Pharmacological modulation of cardiovascular remodeling: A guide to heart failure therapy
-
DOI 10.1023/A:1027351808326
-
W.J. Remme Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy Cardiovasc Drugs Ther 17 2003 349 360 (Pubitemid 37500187)
-
(2003)
Cardiovascular Drugs and Therapy
, vol.17
, Issue.4
, pp. 349-360
-
-
Remme, W.J.1
-
33
-
-
59849089688
-
IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of stat3 and suppression of hur
-
P. Krishnamurthy, J. Rajasingh, E. Lambers, G. Qin, D.W. Losordo, and R. Kishore IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of stat3 and suppression of hur Circ Res 104 2009 e9 18
-
(2009)
Circ Res
, vol.104
, pp. 9-18
-
-
Krishnamurthy, P.1
Rajasingh, J.2
Lambers, E.3
Qin, G.4
Losordo, D.W.5
Kishore, R.6
-
34
-
-
33751107208
-
Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension
-
DOI 10.1161/01.HYP.0000248430.26229.0f, PII 0000426820061200000021
-
I.C. Okere, M.E. Young, T.A. McElfresh, D.J. Chess, V.G. Sharov, and H.N. Sabbah Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension Hypertension 48 2006 1116 1123 (Pubitemid 44772716)
-
(2006)
Hypertension
, vol.48
, Issue.6
, pp. 1116-1123
-
-
Okere, I.C.1
Young, M.E.2
McElfresh, T.A.3
Chess, D.J.4
Sharov, V.G.5
Sabbah, H.N.6
Hoit, B.D.7
Ernsberger, P.8
Chandler, M.P.9
Stanley, W.C.10
-
35
-
-
0030671503
-
Myosin heavy chain gene expression in human heart failure
-
K. Nakao, W. Minobe, R. Roden, M.R. Bristow, and L.A. Leinwand Myosin heavy chain gene expression in human heart failure J Clin Invest 100 1997 2362 2370 (Pubitemid 27500161)
-
(1997)
Journal of Clinical Investigation
, vol.100
, Issue.9
, pp. 2362-2370
-
-
Nakao, K.1
Minobe, W.2
Roden, R.3
Bristow, M.R.4
Leinwand, L.A.5
-
36
-
-
0037458070
-
Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: The aging heart in health: Links to heart disease
-
DOI 10.1161/01.CIR.0000048893.62841.F7
-
E.G. Lakatta, and D. Levy Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part ii. The aging heart in health: links to heart disease Circulation 107 2003 346 354 (Pubitemid 36135235)
-
(2003)
Circulation
, vol.107
, Issue.2
, pp. 346-354
-
-
Lakatta, E.G.1
Levy, D.2
-
37
-
-
34547665415
-
Small-molecule therapies for cardiac hypertrophy: Moving beneath the cell surface
-
DOI 10.1038/nrd2193, PII NRD2193
-
T.A. McKinsey, and D.A. Kass Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface Nat Rev Drug Discov 6 2007 617 635 (Pubitemid 47207749)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.8
, pp. 617-635
-
-
McKinsey, T.A.1
Kass, D.A.2
-
38
-
-
33646099323
-
Temporal changes in dietary fats: Role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity
-
G. Ailhaud, F. Massiera, P. Weill, P. Legrand, J.M. Alessandri, and P. Guesnet Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity Prog Lipid Res 45 2006 203 236
-
(2006)
Prog Lipid Res
, vol.45
, pp. 203-236
-
-
Ailhaud, G.1
Massiera, F.2
Weill, P.3
Legrand, P.4
Alessandri, J.M.5
Guesnet, P.6
-
39
-
-
0033002651
-
Systemic exposure to rosiglitazone is unaltered by food
-
DOI 10.1007/s002280050592
-
M.I. Freed, A. Allen, D.K. Jorkasky, and R.A. DiCicco Systemic exposure to rosiglitazone is unaltered by food Eur J Clin Pharmacol 55 1999 53 56 (Pubitemid 29144100)
-
(1999)
European Journal of Clinical Pharmacology
, vol.55
, Issue.1
, pp. 53-56
-
-
Freed, M.I.1
Allen, A.2
Jorkasky, D.K.3
DiCicco, R.A.4
-
40
-
-
0025286817
-
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
-
B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241 (Pubitemid 20225044)
-
(1990)
New England Journal of Medicine
, vol.323
, Issue.4
, pp. 236-241
-
-
Levine, B.1
Kalman, J.2
Mayer, L.3
Fillit, H.M.4
Packer, M.5
-
41
-
-
21744460998
-
Therapeutic perspectives of adipocytokines
-
DOI 10.1517/14656566.6.6.863
-
S. Kralisch, J. Klein, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Therapeutic perspectives of adipocytokines Expert Opin Pharmacother 6 2005 863 872 (Pubitemid 40946152)
-
(2005)
Expert Opinion on Pharmacotherapy
, vol.6
, Issue.6
, pp. 863-872
-
-
Kralisch, S.1
Klein, J.2
Bluher, M.3
Paschke, R.4
Stumvoll, M.5
Fasshauer, M.6
-
42
-
-
48849108401
-
Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction
-
J.S. Burchfield, M. Iwasaki, M. Koyanagi, C. Urbich, N. Rosenthal, and A.M. Zeiher Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction Circ Res 103 2008 203 211
-
(2008)
Circ Res
, vol.103
, pp. 203-211
-
-
Burchfield, J.S.1
Iwasaki, M.2
Koyanagi, M.3
Urbich, C.4
Rosenthal, N.5
Zeiher, A.M.6
-
43
-
-
0032566405
-
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II
-
K. Nakamura, K. Fushimi, H. Kouchi, K. Mihara, M. Miyazaki, and T. Ohe Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin ii Circulation 98 1998 794 799 (Pubitemid 28391845)
-
(1998)
Circulation
, vol.98
, Issue.8
, pp. 794-799
-
-
Nakamura, K.1
Fushimi, K.2
Kouchi, H.3
Mihara, K.4
Miyazaki, M.5
Ohe, T.6
Namba, M.7
-
44
-
-
33745305434
-
Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice
-
DOI 10.2337/diabetes.55.04.06.db05-0985
-
S. Neschen, K. Morino, J.C. Rossbacher, R.L. Pongratz, G.W. Cline, and S. Sono Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice Diabetes 55 2006 924 928 (Pubitemid 44100165)
-
(2006)
Diabetes
, vol.55
, Issue.4
, pp. 924-928
-
-
Neschen, S.1
Morino, K.2
Rossbacher, J.C.3
Pongratz, R.L.4
Cline, G.W.5
Sono, S.6
Gillum, M.7
Shulman, G.I.8
-
45
-
-
19944369735
-
Adiponectin-mediated modulation of hypertrophic signals in the heart
-
DOI 10.1038/nm1137
-
R. Shibata, N. Ouchi, M. Ito, S. Kihara, I. Shiojima, and D.R. Pimentel Adiponectin-mediated modulation of hypertrophic signals in the heart Nat Med 10 2004 1384 1389 (Pubitemid 40022722)
-
(2004)
Nature Medicine
, vol.10
, Issue.12
, pp. 1384-1389
-
-
Shibata, R.1
Ouchi, N.2
Ito, M.3
Kihara, S.4
Shiojima, I.5
Pimentel, D.R.6
Kumada, M.7
Sato, K.8
Schiekofer, S.9
Ohashi, K.10
Funahashi, T.11
Colucci, W.S.12
Walsh, K.13
-
46
-
-
0037380664
-
Association between adiponectin and mediators of inflammation in obese women
-
DOI 10.2337/diabetes.52.4.942
-
S. Engeli, M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, and J. Janke Association between adiponectin and mediators of inflammation in obese women Diabetes 52 2003 942 947 (Pubitemid 36384264)
-
(2003)
Diabetes
, vol.52
, Issue.4
, pp. 942-947
-
-
Engeli, S.1
Feldpausch, M.2
Gorzelniak, K.3
Hartwig, F.4
Heintze, U.5
Janke, J.6
Mohlig, M.7
Pfeiffer, A.F.H.8
Luft, F.C.9
Sharma, A.M.10
-
47
-
-
50249093156
-
Transcriptome alteration in the diabetic heart by rosiglitazone: Implications for cardiovascular mortality
-
K.D. Wilson, Z. Li, R. Wagner, P. Yue, P. Tsao, and G. Nestorova Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality PLoS One 3 2008 e2609
-
(2008)
PLoS One
, vol.3
, pp. 2609
-
-
Wilson, K.D.1
Li, Z.2
Wagner, R.3
Yue, P.4
Tsao, P.5
Nestorova, G.6
-
48
-
-
1642457244
-
Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats
-
DOI 10.1124/jpet.103.058008
-
J. Song, M.A. Knepper, X. Hu, J.G. Verbalis, and C.A. Ecelbarger Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats J Pharmacol Exp Ther 308 2004 426 433 (Pubitemid 38134200)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.308
, Issue.2
, pp. 426-433
-
-
Song, J.1
Knepper, M.A.2
Hu, X.3
Verbalis, J.G.4
Ecelbarger, C.A.5
-
49
-
-
51549121088
-
Rosiglitazone is cardioprotective in a murine model of myocardial i/r
-
J. Mersmann, N. Tran, P.A. Zacharowski, D. Grotemeyer, and K. Zacharowski Rosiglitazone is cardioprotective in a murine model of myocardial i/r Shock 30 2008 64 68
-
(2008)
Shock
, vol.30
, pp. 64-68
-
-
Mersmann, J.1
Tran, N.2
Zacharowski, P.A.3
Grotemeyer, D.4
Zacharowski, K.5
-
50
-
-
70349231115
-
The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: Role of cardiac phospholipid remodeling
-
K.B. Shah, M.K. Duda, K.M. O'Shea, G.C. Sparagna, D.J. Chess, and R.J. Khairallah The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling Hypertension 54 2009 605 611
-
(2009)
Hypertension
, vol.54
, pp. 605-611
-
-
Shah, K.B.1
Duda, M.K.2
O'Shea, K.M.3
Sparagna, G.C.4
Chess, D.J.5
Khairallah, R.J.6
-
51
-
-
41449110020
-
Prescription omega-3 fatty acids and their lipid effects: Physiologic mechanisms of action and clinical implications
-
H.E. Bays, A.P. Tighe, R. Sadovsky, and M.H. Davidson Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications Expert Rev Cardiovasc Ther 6 2008 391 409
-
(2008)
Expert Rev Cardiovasc Ther
, vol.6
, pp. 391-409
-
-
Bays, H.E.1
Tighe, A.P.2
Sadovsky, R.3
Davidson, M.H.4
-
52
-
-
64149106016
-
N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet
-
O. Kuda, T. Jelenik, Z. Jilkova, P. Flachs, M. Rossmeisl, and M. Hensler N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet Diabetologia 52 2009 941 951
-
(2009)
Diabetologia
, vol.52
, pp. 941-951
-
-
Kuda, O.1
Jelenik, T.2
Jilkova, Z.3
Flachs, P.4
Rossmeisl, M.5
Hensler, M.6
-
53
-
-
38049047703
-
Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats
-
J.A. Johnson, S.E. Trasino, A.W. Ferrante Jr., and J.R. Vasselli Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats Obesity (Silver Spring) 15 2007 2653 2663
-
(2007)
Obesity (Silver Spring)
, vol.15
, pp. 2653-2663
-
-
Johnson, J.A.1
Trasino, S.E.2
Ferrante Jr., A.W.3
Vasselli, J.R.4
-
54
-
-
74549169228
-
Pharmacologic management of the older patient with type 2 diabetes mellitus
-
J.J. Neumiller, and S.M. Setter Pharmacologic management of the older patient with type 2 diabetes mellitus Am J Geriatr Pharmacother 7 2009 324 342
-
(2009)
Am J Geriatr Pharmacother
, vol.7
, pp. 324-342
-
-
Neumiller, J.J.1
Setter, S.M.2
-
55
-
-
67449089733
-
Safety and efficacy of rosiglitazone in the elderly diabetic patient
-
A. Viljoen, and A. Sinclair Safety and efficacy of rosiglitazone in the elderly diabetic patient Vasc Health Risk Manage 5 2009 389 395
-
(2009)
Vasc Health Risk Manage
, vol.5
, pp. 389-395
-
-
Viljoen, A.1
Sinclair, A.2
|